Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
30.73
+1.30 (4.42%)
At close: Mar 9, 2026, 4:00 PM EDT
30.60
-0.13 (-0.42%)
After-hours: Mar 9, 2026, 5:15 PM EDT
Celldex Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -258.76 | -157.86 | -141.43 | -112.33 | -70.51 | |
| Depreciation & Amortization | 3.38 | 3.18 | 3.01 | 2.9 | 3.07 | |
| Loss (Gain) From Sale of Assets | 0.01 | 0.02 | - | 0 | -0.02 | |
| Asset Writedown & Restructuring Costs | - | - | - | - | 3.5 | |
| Loss (Gain) From Sale of Investments | -5.86 | -15.75 | -6.22 | 0.84 | -3.21 | |
| Stock-Based Compensation | 36.22 | 34.24 | 23.89 | 15.61 | 8.95 | |
| Other Operating Activities | - | - | - | -6.86 | -1.63 | |
| Change in Accounts Receivable | -1.32 | 1.93 | -2.28 | -0.18 | 1.57 | |
| Change in Accounts Payable | 11.03 | 11.63 | 9.38 | 3.12 | 3.65 | |
| Change in Other Net Operating Assets | 4.34 | -35.16 | 6.36 | -6.85 | -6.28 | |
| Operating Cash Flow | -210.95 | -157.78 | -107.29 | -103.73 | -60.91 | |
| Capital Expenditures | -2.71 | -1.92 | -1.82 | -1.83 | -1.25 | |
| Sale of Property, Plant & Equipment | - | - | - | 0.07 | 0.03 | |
| Investment in Securities | 211.79 | -288.21 | -103.96 | 91.7 | -214.93 | |
| Investing Cash Flow | 209.07 | -290.13 | -105.78 | 89.94 | -216.16 | |
| Issuance of Common Stock | 2.39 | 441.45 | 218.46 | 4.08 | 272.37 | |
| Financing Cash Flow | 2.39 | 441.45 | 218.46 | 4.08 | 272.37 | |
| Net Cash Flow | 0.52 | -6.46 | 5.39 | -9.71 | -4.69 | |
| Free Cash Flow | -213.66 | -159.7 | -109.11 | -105.56 | -62.16 | |
| Free Cash Flow Margin | -13829.06% | -2274.89% | -1585.19% | -4478.57% | -1336.44% | |
| Free Cash Flow Per Share | -3.22 | -2.48 | -2.25 | -2.25 | -1.45 | |
| Levered Free Cash Flow | -125.54 | -91.67 | -46.7 | -58.03 | -29.71 | |
| Unlevered Free Cash Flow | -125.54 | -91.67 | -46.7 | -58.03 | -29.71 | |
| Change in Working Capital | 14.06 | -21.6 | 13.46 | -3.9 | -1.05 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.